Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention

References

• Saglietto A, Manfredi R, Elia E, et al. Cardiovascular disease burden: Italian and global perspectives. Minerva Cardiol Angiol. 2021;69(3):231–240. doi: 10.23736/S2724-5683.21.05538-9
   PubMedGoogle Scholar
• Mitsis A, Gragnano F. Myocardial infarction with and without ST-segment elevation: a Contemporary Reappraisal of Similarities and Differences. Curr Cardiol Rev Internet. [cited 2023 Feb 9] 2021;17(4):e230421189013. doi: 10.2174/1573403X16999201210195702
   PubMed Web of Science ®Google Scholar
• Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European Society of Intensive Care medicine (ESICM). Eur Heart J. 2008;29(19):2388–2442. doi: 10.1093/eurheartj/ehn309
   PubMed Web of Science ®Google Scholar
• Pascual I, Hernandez-Vaquero D, Almendarez M, et al. Observed and expected Survival in Men and Women after Suffering a STEMI. J Clin Med. 2020 [cited 2023 Feb 9];9(4):1174. Internet. doi: 10.3390/jcm9041174
   PubMed Web of Science ®Google Scholar
• Costa R, Trêpa M, Oliveira M, et al. Heart failure Incidence following ST-Elevation myocardial infarction. Am J Cardiol [Internet]. 2022 [[cited 2023 Feb 9]];164:14–20. doi: 10.1016/j.amjcard.2021.10.035.
   PubMed Web of Science ®Google Scholar
• Mohl W, Gangl C, Jusić A, et al. PICSO: from myocardial salvage to tissue regeneration. Cardiovasc Revascularization Med Mol Interv. 2015;16(1):36–46. doi: 10.1016/j.carrev.2014.12.004
   PubMedGoogle Scholar
• Gibson CM, Ajmi I, von Koenig CL, et al. Pressure-controlled intermittent coronary sinus occlusion: a novel approach to improve microvascular flow and reduce infarct size in STEMI. Cardiovasc Revascularization Med Mol Interv. 2022;S1553-8389(22):00678–9.
   Google Scholar
• Stone GW, Selker HP, Thiele H, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67(14):1674–1683. doi: 10.1016/j.jacc.2016.01.069
   PubMed Web of Science ®Google Scholar
• Egred M, Bagnall A, Spyridopoulos I, et al. Effect of Pressure-controlled intermittent coronary sinus occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study. Int J Cardiol Heart Vasc. 2020;28:100526.
   PubMed Web of Science ®Google Scholar
• Hess CN, Rao SV, McCoy LA, et al. Identification of hospital outliers in bleeding complications after percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes. 2015;8(1):15–22. doi: 10.1161/CIRCOUTCOMES.113.000749
   PubMed Web of Science ®Google Scholar
• Ferreira RM, de Souza E Silva NA, Salis LHA. Complications after elective percutaneous coronary interventions: a comparison between public and private hospitals. Indian Heart J. 2018;70(1):32–36. doi: 10.1016/j.ihj.2017.06.012
   PubMedGoogle Scholar
• A review of JACC articles on the topic of heart rhythm disorders: 2011–2012. J Am Coll Cardiol. [Internet]. 2013 [[cited 2022 Nov 30]];62(21):e451–e519. doi: 10.1016/j.jacc.2013.09.026.
   PubMedGoogle Scholar
• Tehrani S, Laing C, Yellon DM, et al. Contrast-induced acute kidney injury following PCI. Eur J Clin Invest. 2013;43(5):483–490. doi: 10.1111/eci.12061
   PubMed Web of Science ®Google Scholar
• Conto Annuale [Internet]. [cited 2022 Dec 1]. Available from: https://contoannuale.rgs.mef.gov.it/
   Google Scholar
• Ministero dell’Economia e delle Finanze [Internet]. MEF. [cited 2022 Nov 30]. Available from: https://www.mef.gov.it/
   Google Scholar
• Tiemann O. Variations in hospitalisation costs for acute myocardial infarction – a comparison across Europe. Health Econ. 2008;17(S1):S33–45. doi: 10.1002/hec.1322
   PubMedGoogle Scholar
• Husereau D, Drummond M, Augustovski F, et al. Consolidated Health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task force. Value Health J Int Soc PharmacoEcon Outcomes Res. 2022;25:10–31. doi: 10.1016/j.jval.2021.10.008
   Google Scholar
• Tavole di mortalità [Internet]. [cited 2020 May 4]. Available from: http://dati.istat.it/Index.aspx?DataSetCode=DCIS_MORTALITA1
   Google Scholar
• PE guidelines around the world: Italy [Internet]. [cited 2021 May 6]. Available from: https://tools.ispor.org/PEguidelines/countrydet.asp?c=13&t=4
   Google Scholar
• Piscitelli P, Iolascon G, Argentiero A, et al. Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy: comparative analysis based on national hospitalization records. Clin Interv Aging. 2012;7:575–583.
   PubMed Web of Science ®Google Scholar
• Seghieri C, Berta P, Nuti S. Geographic variation in inpatient costs for acute myocardial infarction care: insights from Italy. Health Policy Internet. 2019 [cited 2022 May 29];123(5):449–456. doi: 10.1016/j.healthpol.2019.01.010
   PubMed Web of Science ®Google Scholar
• Corrao G, Ghirardi A, Ibrahim B, et al. Burden of new hospitalization for heart failure: a population-based investigation from Italy. Eur J Heart Fail. 2014;16(7):729–736. doi: 10.1002/ejhf.105
   PubMed Web of Science ®Google Scholar
• Aasa M, Henriksson M, Dellborg M, et al. Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction—results of the Swedish early decision reperfusion study (SWEDES) trial. Am Heart J. 2010;160(2):322–328. doi: 10.1016/j.ahj.2010.05.008
   PubMed Web of Science ®Google Scholar
• Hayes A, Arima H, Woodward M, et al. Changes in quality of life associated with complications of diabetes: results from the ADVANCE study. Value Health J Int Soc PharmacoEcon Outcomes Res. 2016;19:36–41. doi: 10.1016/j.jval.2015.10.010
   Google Scholar
• Proposta di linee guida per la valutazione economica degli interventi sanitari in Italia | SpringerLink [Internet]. [cited 2021 Jul 22]. Available from: https://link.springer.com/article/10.1007/BF03320660
   Google Scholar
• Messori A, Santarlasci B, Trippoli S. Guadagno di sopravvivenza dei nuovi farmaci. PharmacoEconomics Ital Res Artic. PharmacoEconomics Italian Research Articles InternetAvailable from. 2004 [[cited 2021 Jul 22]]; 6(2):95–104. doi: 10.1007/BF03320627
   Google Scholar
• Statistics | Eurostat [Internet]. [cited 2021 Jul 28]. Available from: https://ec.europa.eu/eurostat/databrowser/view/sdg_08_10/default/table?lang=en.
   Google Scholar
• Ferko N, Ferrante G, Hasegawa JT, et al. Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: results from a patient level meta-analysis of randomized trials. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2017;89(6):994–1002. doi: 10.1002/ccd.26700
   PubMed Web of Science ®Google Scholar
• Forné C, Subirana I, Blanch J, et al. A cost-utility analysis of increasing percutaneous coronary intervention use in elderly patients with acute coronary syndromes in six European countries. Eur J Prev Cardiol. 2021;28(4):408–417. doi: 10.1177/2047487320942644
   PubMed Web of Science ®Google Scholar
• Liao C-T, Hsieh T-H, Shih C-Y, et al. Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan. Sci Rep. 2021 [cited 2023 Jul 7];11(1):5608. Internet. doi: 10.1038/s41598-021-84853-y
   PubMed Web of Science ®Google Scholar
• Roggeri DP, Roggeri A, Rossi E, et al. Direct healthcare costs and resource consumption after acute coronary syndrome: a real-life analysis of an Italian subpopulation. Eur J Prev Cardiol. 2014;21(9):1090–1096. doi: 10.1177/2047487313483608
   PubMed Web of Science ®Google Scholar
• Tarricone R, Callea G, Ogorevc M, et al. Improving the methods for the economic evaluation of medical devices. Health Econ. 2017;26(Suppl 1):70–92. doi: 10.1002/hec.3471
   PubMedGoogle Scholar
• Miracor Medical SA A randomized controlled study to evaluate the safety and efficacy of Pressure-controlled intermittent coronary sinus occlusion (PiCSO) in anterior STEMI patients with TIMI 0-2 at presentation. [Internet]. clinicaltrials.Gov. 2022 [cited 2022 Nov 7]. Report No.: NCT05497011. Report No.: NCT05497011: https://clinicaltrials.gov/ct2/show/NCT05497011
   Google Scholar
• Potter S, Davies C, Davies G, et al. The use of micro-costing in economic analyses of surgical interventions: a systematic review. Health Econ Rev. 2020 [cited 2022 Dec 2];10(1):3. InternetAvailable from. doi: https://doi.org/10.1186/s13561-020-0260-8
   PubMed Web of Science ®Google Scholar
• Soares MO, Sharples L, Morton A, et al. Experiences of structured elicitation for model-based cost-effectiveness analyses. Value Health. 2018 [cited 2022 Nov 9];21(6):715–723. Internet. doi: 10.1016/j.jval.2018.01.019
   PubMed Web of Science ®Google Scholar
• Cao Q, Postmus D, Hillege HL, et al. Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease management. Value Health J Int Soc PharmacoEcon Outcomes Res. 2013;16:529–535. doi: 10.1016/j.jval.2013.02.008
   Google Scholar
• Xu X, Lazar CM, Ruger JP. Micro-costing in health and medicine: a critical appraisal. Health Econ Rev InternetAvailable from. 2021 [[cited 2022 Dec 2]]; 11(1):1. doi: 10.1186/s13561-020-00298-5
   PubMed Web of Science ®Google Scholar
• Tarricone R, Amatucci F, Armeni P, et al. Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies. Health Policy. 2021 [cited 2021 Dec 16];125(5):602–608. Internet. doi: 10.1016/j.healthpol.2021.03.003
   PubMed Web of Science ®Google Scholar